Cardiologists received FDA approval for the pediatric use of the algorithm


Philips acquires Cardiologists to expand its cardiac diagnosis and monitoring portfolio

What you should know:

Cardiologists announced today that the FDA has approved its algorithm to use it for the pediatric population, under 18 years of age. His technology can now analyze ECG readings for atrial arrhythmias in all age groups.

Cardiologists, a medical technology company committed to transforming cardiac diagnosis using medical-grade artificial intelligence and cloud technology, announced that it has received 510 (k) clearance from the Food and Drug Administration (FDA). USA to use your Powered by AI Cardiac diagnostic platform for pediatric cardiology.

Support more than 40 million ECG recordings

The new model, now backed by more than 40 million ECG recordings, was used to evaluate a global sample of 10,000 ECG readings from patients of different age groups. The results showed that the updated algorithm improved sensitivity by 14% while reducing the number of false positives by 48% for all major arrhythmias. In addition, arrhythmia detection performance was equal in all age groups, regardless of the ECG recording device.

Recent traction

This is the latest in a series of recent milestones for Cardiologists. Earlier this month, the company announced the results of a new study that showed that its AI model can detect atrial arrhythmias (AA) better than Apple Watch’s electrocardiogram (ECG) algorithm. . Also came the news that Cardiologists are being bought by healthcare technology leader Royal Philips, which plans to use its global footprint to accelerate the adoption of Cardiologs technology worldwide.

Source link